Capital World Investors Amgen Inc Transaction History
Capital World Investors
- $592 Billion
- Q1 2025
A detailed history of Capital World Investors transactions in Amgen Inc stock. As of the latest transaction made, Capital World Investors holds 16,701,609 shares of AMGN stock, worth $4.98 Billion. This represents 0.88% of its overall portfolio holdings.
Number of Shares
16,701,609
Previous 6,495,710
157.12%
Holding current value
$4.98 Billion
Previous $1.69 Billion
207.34%
% of portfolio
0.88%
Previous 0.27%
Shares
10 transactions
Others Institutions Holding AMGN
# of Institutions
3,300Shares Held
426MCall Options Held
8.06MPut Options Held
7.7M-
Vanguard Group Inc Valley Forge, PA52.9MShares$15.8 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.7 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.2MShares$8.7 Billion0.38% of portfolio
-
Morgan Stanley New York, NY16.2MShares$4.84 Billion0.37% of portfolio
-
Capital International Investors Los Angeles, CA15.1MShares$4.51 Billion0.97% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $160B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...